BioSig Technologies [BSGM] vs Nevro [NVRO] Detailed Stock Comparison

BioSig Technologies Inc.

NASDAQ
Loading...

Nevro Corp.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: BioSig Technologies Inc. wins in 6 metrics, Nevro Corp. wins in 10 metrics, with 1 ties. Nevro Corp. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric BioSig Technologies Inc. Nevro Corp. Better
P/E Ratio (TTM) -4.97 144.40 Nevro Corp.
Price-to-Book Ratio -29.71 0.96 Nevro Corp.
Debt-to-Equity Ratio 0.00 108.86 Tie
PEG Ratio -0.03 -2.26 BioSig Technologies Inc.
EV/EBITDA -7.24 -2.15 Nevro Corp.
Profit Margin (TTM) 0.00% -27.77% BioSig Technologies Inc.
Operating Margin (TTM) -211,407.70% -21.79% Nevro Corp.
Return on Equity 739.31% -43.29% BioSig Technologies Inc.
Return on Assets (TTM) -30.45% -9.95% Nevro Corp.
Free Cash Flow (TTM) $-4.76M $-29.23M BioSig Technologies Inc.
1-Year Return -73.04% -56.06% Nevro Corp.
Price-to-Sales Ratio (TTM) 16,550.19 0.55 Nevro Corp.
Enterprise Value $194.33M $180.16M BioSig Technologies Inc.
EV/Revenue Ratio 14,948.37 0.44 Nevro Corp.
Gross Profit Margin (TTM) N/A 62.45% N/A
Revenue per Share (TTM) $0 $11 Nevro Corp.
Earnings per Share (Diluted) $-1.05 $-3.06 BioSig Technologies Inc.
Beta (Stock Volatility) 1.82 0.82 Nevro Corp.
Short % of Float 5.91% N/A N/A

BioSig Technologies Inc. vs Nevro Corp. Stock Performance Analysis

Loading Price Chart...

BSGM
NVRO

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
BioSig Technologies Inc.0.00%17.97%77.65%-31.67%-63.79%-51.45%
Nevro Corp.0.00%N/AN/AN/AN/AN/A

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
BioSig Technologies Inc.-73.04%-88.56%-95.75%-96.61%-98.27%-98.27%
Nevro Corp.-56.06%-92.38%-94.65%-89.12%-76.92%-76.92%

Performance & Financial Health Analysis: BioSig Technologies Inc. vs Nevro Corp.

MetricBSGMNVRO
Market Information
Market Cap i$136.50M$224.09M
Market Cap CategoryMicro capMicro cap
10 Day Avg. Volume i784,1131,058,636
90 Day Avg. Volume i1,297,8421,147,389
Last Close$1.51$5.84
52 Week Range$0.70 - $14.11$3.16 - $13.84
% from 52W High-89.30%-57.80%
All-Time High$124.30 (May 11, 2020)$188.14 (Dec 21, 2020)
% from All-Time High-98.79%-96.90%
Growth Metrics
Quarterly Revenue GrowthN/A-0.09%
Quarterly Earnings Growth-1.00%-0.09%
Financial Health
Profit Margin (TTM) i0.00%-0.28%
Operating Margin (TTM) i-2,114.08%-0.22%
Return on Equity (TTM) i7.39%-0.43%
Debt to Equity (MRQ) i0.00108.86
Cash & Liquidity
Book Value per Share (MRQ)$-0.12$6.11
Cash per Share (MRQ)$0.09$7.72
Operating Cash Flow (TTM) i$-4,356,000$-19,439,000
Levered Free Cash Flow (TTM) i$110.50M$-4,766,875
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: BioSig Technologies Inc. vs Nevro Corp.

MetricBSGM (Nov 18, 2025)NVRO (May 17, 2025)
Price Ratios
P/E Ratio (TTM) i-4.97144.40
Forward P/E i-8.03-2.26
PEG Ratio i-0.03-2.26
Price to Sales (TTM) i16,550.190.55
Price to Book (MRQ) i-29.710.96
Market Capitalization
Market Capitalization i$136.50M$224.09M
Enterprise Value i$194.33M$180.16M
Enterprise Value Metrics
Enterprise to Revenue i14,948.370.44
Enterprise to EBITDA i-7.24-2.15
Risk & Other Metrics
Beta i1.820.82
Book Value per Share (MRQ) i$-0.12$6.11

Financial Statements Comparison: BioSig Technologies Inc. vs Nevro Corp.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricBSGM (2024)NVRO (2024)
Revenue/Sales i40,000408.52M
Cost of Goods Sold iN/A138.99M
COGS % of Revenue i0.0%34.0%
Gross Profit iN/A269.53M
Gross Margin i0.0%66.0%
Research & Development i832,00051.51M
Operating Income (EBIT) i-12.61M-94.70M
Operating Margin i-31,522.5%-23.2%
EBITDA i-14.68M-67.70M
EBITDA Margin i-36,697.5%-16.6%
Pre-Tax Income i-10.34M-112.35M
Pre-Tax Income % of Revenue i-25,847.5%-27.5%
Income Tax i01.09M
Income Tax % of Revenue i0.0%0.3%
Net Income (Profit) i-10.34M-113.44M
Profit Margin i-25,847.5%-27.8%

Balance Sheet & Liquidity Metrics

MetricBSGM (2024)NVRO (2024)
Cash & Equivalents i142,00094.54M
Total Current Assets i344,000476.00M
Total Current Assets % of Revenue i860.0%116.5%
Total Current Liabilities i2.26M102.94M
Total Current Liabilities % of Revenue i5,660.0%25.2%
Long-Term Debt i0213.19M
Long-Term Debt % of Revenue i0.0%52.2%
Total Shareholders Equity i-1.42M231.01M
Retained Earnings i-255.35M-812.85M
Retained Earnings % of Revenue i-638,362.5%-199.0%
Property, Plant & Equipment i818,00036.77M

Cash Flow Statement Comparison

MetricBSGM (2024)NVRO (2024)
Operating Cash Flow i-3.22M-25.99M
Operating Cash Flow % of Revenue i-8,042.5%-6.4%
Capital Expenditures i0-9.79M
Free Cash Flow i-4.76M-29.23M
FCF Margin i-11,895.0%-7.2%
Debt Repayment iN/A0
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricBSGMNVRO
Shares Short i1.75MN/A
Short Ratio i2.24N/A
Short % of Float i5.91%N/A
Shares Outstanding i30.79M37.82M
Float Shares i25.53M34.23M
% Held by Insiders i28.73%2.84%
% Held by Institutions i28.66%110.59%
% Held by Public i42.61%-13.43%

Dividend Analysis & Yield Comparison: BioSig Technologies Inc. vs Nevro Corp.

MetricBSGMNVRO
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A